Health ❯ Healthcare ❯ Pharmaceuticals ❯ Clinical Trials

Cancer Treatments

Ziihera Beats Trastuzumab in Phase 3 GEA Trial as Triple Combo Shows OS Benefit

Jazz targets an H1 2026 sBLA following trial results with no new safety signals.

Inhibrx Drug Extends PFS in Chondrosarcoma Phase 2 as Shares Jump Over 70%